IPO

Renaissance IPO ETF
NYSEARCA

Real-time Quotes | Provided by Morningstar

55.90
-0.07
-0.13%
After Hours: 56.00 +0.1 +0.18% 17:15 10/19 EDT
OPEN
56.52
PREV CLOSE
55.97
HIGH
56.81
LOW
55.59
VOLUME
191.32K
TURNOVER
--
52 WEEK HIGH
57.64
52 WEEK LOW
20.37
TOTAL ASSET
224.25M
YTD YIELD
54.27%
1D
5D
1M
3M
1Y
5Y
News
Performance
Compass Therapeutics files to go public on the Nasdaq
Compass Therapeutics Inc., the Massachusetts-based biopharmaceutical company focused on cancer treatments, has filed to go public. The company, founded in...
MarketWatch · 14h ago
Foghorn Therapeutics sets IPO terms, to raise up to $127.5 million
Foghorn Therapeutics Inc. undefined set terms for its initial public offering Monday, as the Massachusetts-based company focused on the chromatin regulatory...
MarketWatch · 18h ago
Aligos Therapeutics stock rallies out of the gate, then pulls back
Shares of Aligos Therapeutics Inc. undefined rallied out of the gate Friday, as they opened 16% above the initial public offering price. The stock's first...
MarketWatch · 3d ago
Snowflake Stock Is Still Overvalued, Even for a Growth Cloud Company
Cloud data-warehousing company, Snowflake (NYSE:SNOW), founded in 2012, has been one of most-followed IPOs of 2020. On Sept. 16, SNOW stock started trading at an opening price of $245. Source: Blackboard / Shutterstock It was hailed as not only the largest public-debut of this year, but also the biggest software IPO ever. The same day, it hit an all-time high of $319. Now the shares are shy of $250. A data warehouse typically refers to a centralized, secure repository of data.InvestorPlace - Stock Market News, Stock Advice & Trading Tips Researchers from Montclair State University suggest we’re not even close to having enough space to meet our needs. “We need scalable infrastructure and technologies that can access data from multiple disks simultaneously,” the wrote. “Cloud computing provides paradigms for data analytics over such huge datasets.” 7 Marijuana Stocks to Buy That Will Survive 2020 Put another way, we are likely to see the increasing importance of data management within a cloud setting. Therefore, investors wonder whether now would be a good time to buy SNOW stock. If you are not yet a shareholder, you may want to wait on the sidelines until there is further pull-back in the share price. We believe a fall toward $225 would improve the margin of safety for long-term investors. A Closer Look at SNOW Stock According to a recent SEC filing, the company aims to “mobilize the world’s data” and is “reimagining data management for the cloud.” The company believes its platform “enables customers to consolidate data into a single source of truth to drive meaningful business insights, build data-driven applications, and share data,” and “solves the decades-old problem of data silos and data governance.” Put another way, Snowflake’s platform integrates information from different databases within an organization. As a result, that customer can better analyze and in the end utilize the data. A recent study led by Helmut Spengler of the Institute of Medical Informatics, Technical University of Munich, Germany highlights the importance of warehousing platforms to support different use cases and different types of data. Snowflake’s revenue for Q2 FY21 was $133 million. A year ago, the number had been $60 million, and for the six months ended July 31 and 2020, revenue was $104.0 million and $242.0 million, respectively. It meant a YoY growth of 133%. As of end of July, the group had 3,117 customers, which showing an increase from 1,547 customers as of July 31, 2019. Of those 3,117 customers, seven were of the Fortune 10 and 146 were of the Fortune 500 lists, which respectively contributed about 4% and 26% of revenue for the six months ended July 31. The company’s gross profit margins stands well over 50.2%. However, it is still a loss-making entity. Its net loss was $177.2 million and $171.3 million for the six months ended July 31, 2019 and 2020, respectively. Although it might be an encouraging sign to see the net loss level stayed close to constant, it might have also been due to cost-cutting measures prior to the IPO. Should You Buy SNOW Now? Big data is ever-growing, especially with increased digitalization in the days of the pandemic. And investor appetite has fuelled companies serving customers in this space, including young stocks that are not yet profitable. Snowflake is possibly at the right place at the right time. However, even for a growth company, the company is richly valued. Its P/S ratio stands at 132.86. Although the company is expected to grow significantly over the long term, this is an expensive metric. As long as investors are ready to back technology stocks and hot IPO names, SNOW stock could still easily increase in value. However, in the case of a broader market decline, early investors may be ready to hit the sell button, too. We would ideally wait at least several weeks to see the next earnings report as well as put the on-going volatile earnings season behind us. Current shareholders may also consider initiating covered call positions. Such a move would decrease portfolio volatility, provide a cushion against a potential decline, but also enable investors to participate in an up move. An at-the-money (ATM) call with Nov. 20 expiry could be a possible choice. Finally, those investors who are interested in recent IPOs or data and cloud companies may also consider investing in an exchange-traded fund (ETF). Examples would include the Global X Cloud Computing ETF (NASDAQ:CLOU), the Pacer Benchmark Data & Infrastructure Real Estate SCTR ETF (NYSEARCA:SRVR), and the Renaissance IPO ETF (NYSEARCA:IPO). On the date of publication, Tezcan Gecgil did not have (either directly or indirectly) any positions in the securities mentioned in this article. Tezcan Gecgil has worked in investment management for over two decades in the U.S. and U.K. In addition to formal higher education in the field, she has also completed all 3 levels of the Chartered Market Technician (CMT) examination. Her passion is for options trading based on technical analysis of fundamentally strong companies. She especially enjoys setting up weekly covered calls for income generation. She also publishes educational articles on long-term investing. More From InvestorPlace Forget The Election… Pick These Stocks for the Win in 2021 Why Everyone Is Investing in 5G All WRONG America’s #1 Stock Picker Reveals His Next 1,000% Winner Revolutionary Tech Behind 5G Rollout Is Being Pioneered By This 1 Company The post Snowflake Stock Is Still Overvalued, Even for a Growth Cloud Company appeared first on InvestorPlace.
InvestorPlace · 3d ago
Aligos Therapeutics raises $150 million as IPO prices at middle of expected range
Aligos Therapeutics Inc.'s undefined initial public offering priced late Thursday at $15 a share, in the middle of the expected range of between $14 and $16...
MarketWatch · 3d ago
Array Technologies stock surges in public debut, as solar company is valued at $2.8 billion at IPO price
Shares of Array Technologies Inc. undefined charged out of the gate, as the first trade was 34% above where the upsized initial public offering priced. A...
MarketWatch · 4d ago
Praxis Precision Medicines upsizes IPO by 35%, now looks to raise up to $180 million
Praxis Precision Medicines Inc. undefined has increased the number of shares it plans to sell in its initial public offering by 35%, as the...
MarketWatch · 4d ago
IPO ETF: A Banner Year, But The High Turnover Adds To Risks
The Renaissance IPO ETF invests in companies that launched an initial public offering within the last two years of trading.11 new stocks were added to the fund, and 7 dropped in September during the last quarterly index change.Several high-profile and top-performing holdings are on track to be removed in upcoming index reconstitutions.IPO is a good option for investors to gain exposure to new companies and emerging stocks, although we highlight the extreme turnover adds to risks.
Seekingalpha · 4d ago
More
No Data
Learn about the latest financial forecast of IPO. Analyze the recent business situations of Renaissance IPO ETF through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
Ratings
Date
Period
Agency
Ratings
08/31/2020
3 Year
Morningstar
08/31/2020
5 Year
Morningstar
  • Performance
  • Asset Allocation
  • Dividend History
Period
Return
Rank in Cat
1-Month
4.5211%
--
3-Month
24.3965%
--
6-Month
52.2629%
--
1-Year
54.2736%
--
3-Year
22.5719%
--
5-Year
17.8868%
--
Since Inception
14.0385%
--
No Data
  • Dividends
  • Splits
  • Insider Activity
No Data
  • All
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
Profile
Fund Name
Renaissance IPO ETF
Risk
Medium-low risk
Inception Date
2013-10-16
Benchmark
Russell MidCap Growth TR
Advisor Company
Renaissance Capital
Custodian
State Street Bank & Trust Co
Manager
William K. Smith